Allergan Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | 681.9 | 792.5 | 746.9 |
| Net Investing Cash Flow | (459.1) | (833.1) | (1,484.6) |
| Net Financing Cash Flow | (262.8) | (182.4) | 803.0 |
| Net Change in Cash | (47.5) | (211.5) | 73.1 |
| Depreciation & Amortization | 150.9 | 121.3 | 79.6 |
| Capital Expenditures | (190.2) | (141.8) | (131.4) |
| Cash Dividends Paid | (60.7) | (60.8) | (58.4) |
© 2009 Morningstar, Inc. Financial Data provided by
